We also found higher expression of MED15 in ccRCC than in normal kidney tissues in clinical samples, and the expression level of MED15 was positively correlated with tumor stage, suggesting that MED15 has the potential to be a biomarker of prognosis in ccRCC. This evidence concerns the gene MED15 and nonpapillary renal cell carcinoma.